ZA-17 5mg (Bromocriptine Mesylate 5 mg)
Pill with imprint ZA-17 5mg is Tan & White, Capsule-shape and has been identified as Bromocriptine Mesylate 5 mg. It is supplied by Zydus Pharmaceuticals.
Bromocriptine is used in the treatment of hyperprolactinemia; parkinson's disease; acromegaly; diabetes, type 2 and belongs to the drug classes dopaminergic antiparkinsonism agents, prolactin inhibitors. There is no proven risk in humans during pregnancy. Bromocriptine 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ZA-17 5mg
Bromocriptine Mesylate
- Imprint
- ZA-17 5mg
- Strength
- 5 mg
- Color
- Tan & White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents, Prolactin inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals
- National Drug Code (NDC)
- 68382-0110
- Inactive Ingredients
-
lactose monohydrate,
magnesium stearate,
maleic acid,
silicon dioxide,
titanium dioxide,
carrageenan,
hypromellose 2910 (15 mPa.s),
ferric oxide red,
potassium hydroxide,
ferrosoferric oxide,
butyl alcohol,
alcohol,
isopropyl alcohol,
propylene glycol,
water,
shellac,
ammonia
Note: Inactive ingredients may vary.
More about bromocriptine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (30)
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: dopaminergic antiparkinsonism agents
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
